Open Access
| Issue |
BIO Web Conf.
Volume 174, 2025
2025 7th International Conference on Biotechnology and Biomedicine (ICBB 2025)
|
|
|---|---|---|
| Article Number | 02007 | |
| Number of page(s) | 5 | |
| Section | Innovations in Therapeutics and Disease Mechanisms | |
| DOI | https://doi.org/10.1051/bioconf/202517402007 | |
| Published online | 12 May 2025 | |
- Pavelić, Željka, Nataša Škalko-Basnet, and Rolf Schubert. “Liposomal gels for vaginal drug delivery.” International journal of pharmaceutics 219.1-2 (2001): 139-149. [Google Scholar]
- Yadav, Krishna, et al. “Commercial aspects and market potential of novel delivery systems for bioactives and biological agents.” Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents. Academic Press, 2020. 595-620. [Google Scholar]
- Chawla, Viney, and Shubhini A. Saraf. “Rheological studies on solid lipid nanoparticle based carbopol gels of aceclofenac.” Colloids and Surfaces B: Biointerfaces 92 (2012): 293-298. [CrossRef] [Google Scholar]
- Yang, Ziyi, et al. “Vagina, a promising route for drug delivery.” Journal of Drug Delivery Science and Technology, vol. 93, Mar. 2024, p. 105397. [CrossRef] [Google Scholar]
- Subi, M. Tamil Mani, et al. “Vaginal drug delivery system: A promising route of drug administration for local and systemic diseases.” Drug Discovery Today, vol.29, no.6, June 2024, p. 104012. https://doi.org/10.1016/j.drudis.2024.104012. [CrossRef] [PubMed] [Google Scholar]
- McConville, Christopher. “The Use of Localised Vaginal Drug Delivery as Part of a Neoadjuvant Chemotherapy Strategy in the Treatment of Cervical Cancer.” Gynecology and Obstetrics Research-Open Journal, vol.2, no.1, May 2015, pp.26–28. https://doi.org/10.17140/goroj-2-106. [CrossRef] [Google Scholar]
- Ramsey, Patrick S., et al. “Effect of vaginal pH on efficacy of the dinoprostone gel for cervical ripening/labor induction.” American Journal of Obstetrics and Gynecology, vol. 187, no. 4, Oct. 2002, pp. 843–46. https://doi.org/10.1067/mob.2002.126987. [CrossRef] [PubMed] [Google Scholar]
- Giordani, Stefano, et al. “Liposomes characterization for market approval as pharmaceutical products: Analytical methods, guidelines and standardized protocols.” Journal of Pharmaceutical and Biomedical Analysis (2023): 115751. [Google Scholar]
- Škalko, Nataša, et al. “Liposomes with nifedipine and nifedipine-cyclodextrin complex: calorimetrical and plasma stability comparison.” European journal of pharmaceutical sciences 4.6 (1996): 359-366. [Google Scholar]
- Kandula, Sharanya, et al. “Trends in smart drug delivery systems for targeting cancer cells.” Materials Science and Engineering: B 297 (2023): 116816. [CrossRef] [Google Scholar]
- Vasir, Jaspreet K., and Vinod Labhasetwar. “Targeted drug delivery in cancer therapy.” Technology in cancer research & treatment 4.4 (2005): 363-374. [CrossRef] [PubMed] [Google Scholar]
- Kandula, Sharanya, et al. “Trends in smart drug delivery systems for targeting cancer cells.” Materials Science and Engineering: B 297 (2023): 116816. [CrossRef] [Google Scholar]
- Kim, Jinseong, et al. “Perspectives for improving the tumor targeting of nanomedicine via the EPR effect in clinical tumors.” International journal of molecular sciences 24.12 (2023): 10082. [CrossRef] [PubMed] [Google Scholar]
- Barenholz Y. Doxil®--the first FDA-approved nano-drug: lessons learned. J Control Release. 2012 Jun 10;160(2):117-34. doi:10.1016/j.jconrel.2012.03.020. Epub 2012 Mar 29. PMID: 22484195. [CrossRef] [Google Scholar]
- Green, M R et al. “Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer.” Annals of oncology: official journal of the European Society for Medical Oncology vol. 17,8 (2006): 1263-8. doi:10.1093/annonc/mdl104 [CrossRef] [Google Scholar]
- Zhao, Nan, et al. “Fe3O4 Composite Superparticles with RGD/Magnetic Dual-Targeting Capabilities for the Imaging and Treatment of Non-Small Cell Lung Cancer.” ACS omega 8.8 (2023): 7891-7903. [CrossRef] [PubMed] [Google Scholar]
- Karthikeyan, Laxmanan, and Raju Vivek. “Synergistic anti-cancer effects of NIR-light responsive nanotherapeutics for chemo-photothermal therapy and photothermal immunotherapy: A combined therapeutic approach.” Advances in Cancer Biology-Metastasis 4 (2022): 100044. [CrossRef] [Google Scholar]
- Wu, Sheng-Kai, et al. “Focused ultrasound and microbubbles-mediated drug delivery to brain tumor.” Pharmaceutics 13.1 (2020): 15. [CrossRef] [PubMed] [Google Scholar]
- Dutta, Bijaideep, K. C. Barick, and P. A. Hassan. “Recent advances in active targeting of nanomaterials for anticancer drug delivery.” Advances in colloid and interface science 296 (2021): 102509. [CrossRef] [PubMed] [Google Scholar]
- Pander, Giulia, et al. “Antibody–drug conjugates: What drives their progress?.” Drug Discovery Today 27.10 (2022): 103311. [CrossRef] [PubMed] [Google Scholar]
- Delgado, J., et al. “The EMA review of trastuzumab emtansine (T-DM1) for the adjuvant treatment of adult patients with HER2-positive early breast cancer.” ESMO open 6.2 (2021): 100074. [CrossRef] [PubMed] [Google Scholar]
- Fu, Chen, et al. “Peptide–drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?.” Acta Pharmaceutica Sinica B 13.2 (2023): 498-516. [CrossRef] [PubMed] [Google Scholar]
- Li, Hui, et al. “Acid-Activated TAT Peptide-Modified Biomimetic Boron Nitride Nanoparticles for Enhanced Targeted Codelivery of Doxorubicin and Indocyanine Green: A Synergistic Cancer Photothermal and Chemotherapeutic Approach.” ACS Applied Materials & Interfaces 16.19 (2024): 25101-25112. [CrossRef] [PubMed] [Google Scholar]
- Zhong, Lei, et al. “Small molecules in targeted cancer therapy: advances, challenges, and future perspectives.” Signal transduction and targeted therapy 6.1 (2021): 1-48. [Google Scholar]
- Kaur, Navjeet, et al. “Small molecules as cancer targeting ligands: Shifting the paradigm.” Journal of Controlled Release 355 (2023): 417-433. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.